Boston Heart Diagnostics Corp.

  • August 2, 2017

Framingham, Massachusetts 2019 Boston Heart Diagnostics Corp. filed separate patent infringement lawsuits, one against GeneAlign, LLC (17-cv-11412) and the other against Genelex Corp. (17-cv-11416). Both suits allege infringement of U.S. Patent No. 8,455,194, titled 201cDiagnostic Methods 201d and directed to methods for detecting the susceptibility of an individual to statin-induced myopathy, and the plaintiff alleges itself to be the exclusive licensee with the 201cfirst right 201d to sue for infringement. Plaintiff alleges direct and induced infringement.

By submitting this form, you are consenting to receive marketing emails from: Lando & Anastasi, LLP. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

SHARE THIS POST

How can we help you?

Get in Touch